He will support efforts to take New Jersey's drug cost caps to the national level.

Herbert C. Conaway, Jr. · New Jersey · Democratic

policy impact 0.84 specificity 0.83 extraction confidence 95%

Occurrences

Because these issues are so dear to my heart, I will support efforts that take New Jersey’s life-saving drug cost caps to the national level.

Promises to back federal prescription drug cost-cap efforts modeled on New Jersey policy.

Issues | Herb Conaway
campaign · campaign_site · model gpt-5.4-mini

Evidence

Sponsor: Rep. Conaway, Herbert C. [D-NJ-3] (Introduced 11/10/2025). Committees: House - Veterans' Affairs. Latest Action: House - 01/13/2026 Subcommittee Hearings Held. Committee activity is listed for 11/10/2025 referral, 11/17/2025 referral to the Subcommittee on Health, and 01/13/2026 hearings by the subcommittee.

Conaway advanced a veterans bill into subcommittee hearings, but it is not a prescription-drug cost-cap measure; the bill remains introduced and unpassed.

unresolved same_term A for effort

H.R.5999 - Committees | Congress.gov
secondary · model gpt-5.4-mini · confidence 78%

Committee on Veterans’ Affairs: Full Committee held a markup on H.R. 5999, the 'Veteran Opioid Emergency Treatment Act' ... H.R. 5999 was ordered reported, as amended.

Within the lookback window, Conaway's bill moved through committee markup and was ordered reported, but the recorded measure is an opioid-antagonist access bill rather than a national prescription drug cost-cap bill.

unresolved same_term A for effort

CREC-2026-05-14-pt1-PgD513-2.pdf
secondary · model gpt-5.4-mini · confidence 83%

Congress.gov's member page for Herbert C. Conaway, Jr. shows no matches for "drug," "price," "cost," "cap," "insulin," or "prescription drug" on the page search, and the only prescription-related sponsored bill surfaced is H.R.5999, whose latest action is listed as House - 01/13/2026 Subcommittee Hearings Held. That points to no documented national drug-cost-cap effort in the lookback window.

Official congressional records do not show a June 22-24, 2026 drug-cost-cap action by Conaway; the closest visible activity is an unrelated opioid-antagonist access bill.

unresolved same_term

Herbert C. Conaway, Jr. | Congress.gov | Library of Congress
primary · model gpt-5.4-mini · confidence 90%

Assessments

unresolved unknown

Official congressional records in the provided evidence do not show Herbert C. Conaway, Jr. advancing New Jersey-style drug cost caps to the national level. The only documented legislative activity is an unrelated veterans opioid-access bill, which is not the promised policy. That is insufficient to mark the promise delivered or even partially delivered on the specific claim.

provider codex_cli · model gpt-5.4-mini · confidence 88%

unresolved unknown

The provided evidence shows Conaway sponsored or advanced H.R. 5999, a veterans opioid emergency treatment/opioid-antagonist access measure, not a national prescription drug cost-cap bill modeled on New Jersey's drug cost caps. There is no evidence in the payload that he supported, sponsored, voted for, or materially advanced a federal drug cost-cap effort, and no evidence that such a national cap was enacted. Because the relevant promise-specific evidence is missing rather than clearly disproving any attempt, the claim remains unresolved rather than delivered or never.

provider codex_cli · model gpt-5.5 · confidence 78%